SCHEMBL516366

SCHEMBL516366

[O]C1CNCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15865375 0.82
SCHEMBL16612279 0.69
SCHEMBL431279 0.67 HIF1A (0.33)
SCHEMBL27415328 0.65 ALPL (0.36)
SCHEMBL16558 0.65
SCHEMBL27810538 0.65
SCHEMBL28206655 0.65
SCHEMBL17120 0.65
SCHEMBL16559 0.65
SCHEMBL3850753 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107574683-A A kind of method that bafta gloss and wrinkle resistance are improved with decatize decoration method 青岛大学 2018-01-12 CN claimed
WO-2024080788-A1 NOVEL TRICYCLIC DERIVATIVE COMPOUND AND USES THEREOF 한미약품 주식회사 2024-04-18 WO disclosed
CN-108938634-B Effect of PARP inhibitors in promoting Targeted endoderm production 杭州瑞普晨创科技有限公司 2022-08-05 CN disclosed
US-RE49080-E1 Glycoside derivatives and uses thereof NOVARTIS AG (CH) 2022-05-24 US disclosed
US-11040028-B2 Penicinotam derivative, preparation method and use thereof OCEAN UNIVERSITY OF CHINA (CN) 2021-06-22 US disclosed
US-10993938-B2 Lactam compound, preparation method and use thereof OCEAN UNIVERSITY OF CHINA (CN) 2021-05-04 US disclosed
US-20210008045-A1 PANICINOTAM DERIVATIVE, PREPARATION METHOD AND USE THEREOF OCEAN UNIVERSITY OF CHINA (CN) 2021-01-14 US disclosed
CN-108490184-B Application of human POT1 protein in leukemia diagnosis 中国科学院化学研究所 2021-01-08 CN disclosed
EP-3083588-B1 AROMATIC HETEROCYCLIC COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS SUNSHINE LAKE PHARMA CO LTD (CN) 2020-12-09 EP disclosed
US-20200030312-A1 Lactam Compound, Preparation Method and Use thereof OCEAN UNIVERSITY OF CHINA (CN) 2020-01-30 US disclosed
US-20100081825-A1 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE TAISHO PHARMACEUTICAL CO LTD (JP) 2010-04-01 US disclosed
EP-2098509-A1 1-NAPHTHYL ALKYLPIPERIDINE DERIVATIVE Taisho Pharmaceutical Co. Ltd. (JP) 2009-09-09 EP disclosed
US-7563916-B2 Process for producing an alcohol or a silyl ether thereof TAKASAGO INTERNATIONAL CORPORATION (JP) 2009-07-21 US disclosed
US-20060199973-A1 Process for producing an alcohol or a silyl ether thereof TAKASAGO INTERNATIONAL CORPORATION (JP) 2006-09-07 US disclosed
EP-1698609-A1 Process for producing an alcohol or its silyl ether Takasago International Corporation (JP) 2006-09-06 EP disclosed
US-6444696-B1 1-ARYL OR HETEROARYL SUBSTITUTED 5-AMINO-4 CARBONYLPYRAZOLE DERIVATIVES; ANTIINFLAMMATORY AGENTS SYNTEX (U.S.A.) LLC 2002-09-03 US disclosed
US-20020103245-A1 Pyrazole derivatives P38 MAP kinase inhibitors GOLDSTEIN DAVID MICHAEL (US) 2002-08-01 US disclosed
EP-1218346-A1 PYRAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-07-03 EP disclosed
US-6316466-B1 Pyrazole derivatives P-38 MAP kinase inhibitors SYNTEX (U.S.A.) LLC 2001-11-13 US disclosed
WO-2001021591-A1 PYRAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2001-03-29 WO disclosed